Carla Yunis Selected Research

atorvastatin drug combination amlodipine

1/2014	Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.
5/2013	Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (≥ 65 years) patients in the CRUCIAL trial.
7/2012	Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.
4/2011	Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial.
11/2010	Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?
5/2010	Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
1/2009	The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla Yunis Research Topics

Disease

9	Hypertension (High Blood Pressure) 07/2018 - 03/2002
5	Coronary Disease (Coronary Heart Disease) 01/2014 - 03/2010
3	Myocardial Infarction 07/2018 - 05/2013
3	Stroke (Strokes) 07/2018 - 05/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2016 - 01/2009
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2018 - 08/2016
2	Injection Site Reaction 01/2017 - 01/2017
2	Hypotension (Low Blood Pressure) 12/2013 - 01/2009
2	Neoplasms (Cancer) 12/2007 - 08/2007
1	Fibrosis (Cirrhosis) 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2018
1	Ischemic Colitis 10/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Unstable Angina 01/2017
1	Vascular Diseases (Vascular Disease) 08/2016
1	Cough 01/2014
1	Bronchitis 01/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Nausea 09/2013
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2013
1	Tobacco Use Disorder (Nicotine Dependence) 12/2012
1	Psychotic Disorders (Schizoaffective Disorder) 05/2012
1	Schizophrenia (Dementia Praecox) 05/2012
1	Stable Angina 11/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2010
1	Dyslipidemias (Dyslipidemia) 01/2009
1	Body Weight (Weight, Body) 01/2002

Drug/Important Bio-Agent (IBA)

7	atorvastatin drug combination amlodipine FDA Link 01/2014 - 01/2009
5	LipidsIBA 01/2017 - 05/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2009
4	bococizumabIBA 07/2018 - 08/2016
4	CholesterolIBA 08/2016 - 03/2010
4	Amlodipine (Norvasc)FDA LinkGeneric 11/2010 - 01/2009
3	LDL CholesterolIBA 07/2018 - 11/2010
3	Varenicline (Chantix)FDA Link 09/2013 - 05/2012
3	Atorvastatin (Lipitor)FDA Link 11/2010 - 01/2009
2	oxidized low density lipoproteinIBA 07/2018 - 08/2016
2	lipoprotein cholesterolIBA 12/2013 - 01/2009
2	spiropentaneacetic acid (SPAA)IBA 05/2013 - 07/2012
2	Antihypertensive Agents (Antihypertensives)IBA 04/2011 - 03/2002
2	Toll-Like Receptor 7IBA 12/2007 - 08/2007
2	SodiumIBA 11/2002 - 01/2002
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Pharmaceutical PreparationsIBA 10/2017
1	GoldIBA 01/2014
1	Tiotropium Bromide (Spiriva)FDA Link 01/2014
1	Triglycerides (Triacylglycerol)IBA 12/2013
1	omega-Chloroacetophenone (Mace)IBA 05/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2009
1	N- (4- (4- amino- 2- ethyl- 1H- imidazo(4,5c)quinolin- 1- yl)butyl)methanesulfonamideIBA 12/2007
1	PotassiumIBA 11/2002
1	CreatinineIBA 01/2002
1	Indicators and Reagents (Reagents)IBA 01/2002

Therapy/Procedure

7	Therapeutics 01/2017 - 01/2009
1	Drug Therapy (Chemotherapy) 01/2014
1	Secondary Prevention 01/2014
1	Surgical Decompression 04/2002